These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18374414)

  • 1. CD40 ligand supports the long-term maintenance and differentiation of chicken B cells in culture.
    Kothlow S; Morgenroth I; Tregaskes CA; Kaspers B; Young JR
    Dev Comp Immunol; 2008; 32(9):1015-26. PubMed ID: 18374414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand.
    Bishop GA; Warren WD; Berton MT
    Eur J Immunol; 1995 May; 25(5):1230-8. PubMed ID: 7539751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and characterization of agonistic monoclonal antibodies against chicken CD40.
    Chen CH; Abi-Ghanem D; Njongmeta L; Bray J; Mwangi W; Waghela SD; McReynolds JL; Ing NH; Berghman LR
    Dev Comp Immunol; 2010 Nov; 34(11):1139-43. PubMed ID: 20599554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of B cells using Schneider 2 cells expressing CD40 ligand for the enhancement of antigen presentation in vitro.
    Yoon SH; Cho HI; Kim TG
    Exp Mol Med; 2005 Dec; 37(6):567-74. PubMed ID: 16391518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40-CD40 ligand interactions stimulate B cell antigen processing.
    Faassen AE; Dalke DP; Berton MT; Warren WD; Pierce SK
    Eur J Immunol; 1995 Dec; 25(12):3249-55. PubMed ID: 8566008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
    Hirohata S
    Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiation.
    Duhen T; Pasero C; Mallet F; Barbarat B; Olive D; Costello RT
    Eur J Immunol; 2004 Dec; 34(12):3534-41. PubMed ID: 15549770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism.
    Dranitzki-Elhalel M; Huang JH; Sasson M; Rachmilewitz J; Parnas M; Tykocinski ML
    Int Immunol; 2007 Apr; 19(4):355-63. PubMed ID: 17314083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Establishment of long-term culture system for human B cells derived from peripheral blood mononuclear cells activated via soluble CD40 ligand].
    Wu C; Liu Y; Zhao Q; Chen GM; Chen JH; Yan XM; Zhou YH; Huang ZH
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):124-7. PubMed ID: 19489277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation.
    Hermann P; Van-Kooten C; Gaillard C; Banchereau J; Blanchard D
    Eur J Immunol; 1995 Oct; 25(10):2972-7. PubMed ID: 7589100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine model of CD40-activation of B cells.
    Liebig TM; Fiedler A; Klein-Gonzalez N; Shimabukuro-Vornhagen A; von Bergwelt-Baildon M
    J Vis Exp; 2010 Mar; (37):. PubMed ID: 20208476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of polar interactions in the molecular recognition of CD40L with its receptor CD40.
    Singh J; Garber E; Van Vlijmen H; Karpusas M; Hsu YM; Zheng Z; Naismith JH; Thomas D
    Protein Sci; 1998 May; 7(5):1124-35. PubMed ID: 9605317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response.
    Jaiswal AI; Croft M
    J Immunol; 1997 Sep; 159(5):2282-91. PubMed ID: 9278317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC.
    Ivanov R; Aarts T; Hagenbeek A; Hol S; Ebeling S
    Cytotherapy; 2005; 7(1):62-73. PubMed ID: 16040385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mitogen fusion protein against CD40+ cells with potent vaccine adjuvant properties.
    Yoshida T; Yoshida R; Ma BY; Mikolajczak S; Kelvin DJ; Ochi A
    Vaccine; 2010 May; 28(21):3688-95. PubMed ID: 20359561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40L--a costimulatory molecule involved in the maturation of antigen presenting cells in Atlantic salmon (Salmo salar).
    Lagos LX; Iliev DB; Helland R; Rosemblatt M; Jørgensen JB
    Dev Comp Immunol; 2012 Nov; 38(3):416-30. PubMed ID: 22889889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production.
    Glaum MC; Narula S; Song D; Zheng Y; Anderson AL; Pletcher CH; Levinson AI
    J Allergy Clin Immunol; 2009 Jan; 123(1):224-230.e4. PubMed ID: 18995892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-3.
    Kindler V; Zubler RH
    J Immunol; 1997 Sep; 159(5):2085-90. PubMed ID: 9278293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A membrane-bound form of IL-4 enhances proliferation and antigen presentation of CD40-activated human B cells.
    Park JY; Yoon SH; Kim EK; Yun SO; Park MY; Sohn HJ; Kim TG
    Immunol Lett; 2008 Feb; 116(1):33-40. PubMed ID: 18096249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential immaturity of the T-cell and antigen-presenting cell interaction in cord blood with particular emphasis on the CD40-CD40 ligand costimulatory pathway.
    Han P; McDonald T; Hodge G
    Immunology; 2004 Sep; 113(1):26-34. PubMed ID: 15312133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.